BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35850266)

  • 1. Downregulation of annexin A3 promotes ionizing radiation-induced EGFR activation and nuclear translocation and confers radioresistance in nasopharyngeal carcinoma.
    Yang L; Lu P; Yang X; Li K; Chen X; Zhou Y; Qu S
    Exp Cell Res; 2022 Sep; 418(2):113292. PubMed ID: 35850266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma.
    Liao L; Yan WJ; Tian CM; Li MY; Tian YQ; Zeng GQ
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617750309. PubMed ID: 29357787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHAF1B induces radioresistance by promoting DNA damage repair in nasopharyngeal carcinoma.
    Di M; Wang M; Miao J; Chen B; Huang H; Lin C; Jian Y; Li Y; Ouyang Y; Chen X; Wang L; Zhao C
    Biomed Pharmacother; 2020 Mar; 123():109748. PubMed ID: 31869663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
    Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
    Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance by Targeting A20/NF-κB Signaling Pathway.
    Li LN; Xiao T; Yi HM; Zheng Z; Qu JQ; Huang W; Ye X; Yi H; Lu SS; Li XH; Xiao ZQ
    Mol Cancer Ther; 2017 Oct; 16(10):2094-2106. PubMed ID: 28698199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of annexin VII enhances nasopharyngeal carcinoma cell radiosensitivity in vivo and in vitro.
    Gui SJ; Ding RL; Wan YP; Zhou L; Chen XJ; Zeng GQ; He CZ
    Cancer Biomark; 2020; 28(2):129-139. PubMed ID: 31958076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling.
    Qu JQ; Yi HM; Ye X; Zhu JF; Yi H; Li LN; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Xiao ZQ
    Mol Cancer Ther; 2015 Nov; 14(11):2653-64. PubMed ID: 26304234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy.
    Chang L; Huang J; Wang K; Li J; Yan R; Zhu L; Ye J; Wu X; Zhuang S; Li D; Zhang G
    BMC Cancer; 2016 Mar; 16():190. PubMed ID: 26951044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p.
    Huang W; Shi G; Yong Z; Li J; Qiu J; Cao Y; Zhao Y; Yuan L
    Cell Death Dis; 2020 Jul; 11(7):504. PubMed ID: 32632129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
    He W; Jin H; Liu Q; Sun Q
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA CASC19 Contributes to Radioresistance of Nasopharyngeal Carcinoma by Promoting Autophagy via AMPK-mTOR Pathway.
    Liu H; Zheng W; Chen Q; Zhou Y; Pan Y; Zhang J; Bai Y; Shao C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway.
    Nie X; Guo E; Wu C; Liu D; Sun W; Zhang L; Long G; Mei Q; Wu K; Xiong H; Hu G
    Cancer Med; 2019 Apr; 8(4):1779-1792. PubMed ID: 30907073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
    Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
    Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation.
    Wang S; Zhang R; Claret FX; Yang H
    Mol Cancer Ther; 2014 Dec; 13(12):3163-74. PubMed ID: 25319395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LINC00173 induces radioresistance in nasopharyngeal carcinoma via inhibiting CHK2/P53 pathway.
    Miao J; Chen B; Xiao Y; Huang R; Xiao X; Lu S; Zhang L; Wang X; Ouyang Y; Chen X; Chen Q; Xiang Y; Guo X; Deng X; Wang L; Mai H; Zhao C
    Cancer Gene Ther; 2023 Sep; 30(9):1249-1259. PubMed ID: 37258811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma.
    Wang Z; Zuo W; Zeng Q; Li Y; Lu T; Bu Y; Hu G
    Int J Biol Sci; 2020; 16(3):408-419. PubMed ID: 32015678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing NFBD1/MDC1 enhances the radiosensitivity of human nasopharyngeal cancer CNE1 cells and results in tumor growth inhibition.
    Wang Z; Zeng Q; Chen T; Liao K; Bu Y; Hong S; Hu G
    Cell Death Dis; 2015 Aug; 6(8):e1849. PubMed ID: 26247734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional pausing induced by ionizing radiation enables the acquisition of radioresistance in nasopharyngeal carcinoma.
    Liu H; Fu H; Yu C; Zhang N; Huang C; Lv L; Hu C; Chen F; Xiao Z; Zhang Z; Lu H; Yuan K
    J Mol Cell Biol; 2024 Jan; 15(7):. PubMed ID: 37407287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PPP1CC promotes NHEJ-mediated DNA repair leading to radioresistance and poor prognosis in nasopharyngeal carcinoma.
    Feng P; Wang Y; Liu N; Chen Y; Hu Y; Huang Z; Liu Y; Zheng S; Jiang T; Xiao X; Dai W; Huang P; Xia Y
    Cell Death Differ; 2024 May; 31(5):683-696. PubMed ID: 38589496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.